HomeCompareSRACW vs XYLD

SRACW vs XYLD: Dividend Comparison 2026

SRACW yields 85.47% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SRACW wins by $2.09M in total portfolio value
10 years
SRACW
SRACW
● Live price
85.47%
Share price
$2.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.11M
Annual income
$639,398.81
Full SRACW calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — SRACW vs XYLD

📍 SRACW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSRACWXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SRACW + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SRACW pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SRACW
Annual income on $10K today (after 15% tax)
$7,264.96/yr
After 10yr DRIP, annual income (after tax)
$543,488.99/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, SRACW beats the other by $540,752.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SRACW + XYLD for your $10,000?

SRACW: 50%XYLD: 50%
100% XYLD50/50100% SRACW
Portfolio after 10yr
$1.07M
Annual income
$321,308.91/yr
Blended yield
30.08%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SRACW buys
0
XYLD buys
0
No recent congressional trades found for SRACW or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSRACWXYLD
Forward yield85.47%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$2.11M$25.3K
Annual income after 10y$639,398.81$3,219.02
Total dividends collected$1.85M$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SRACW vs XYLD ($10,000, DRIP)

YearSRACW PortfolioSRACW Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$19,247$8,547.01$10,818$1,098.39+$8.4KSRACW
2$35,969$15,374.24$11,738$1,222.51+$24.2KSRACW
3$65,338$26,851.55$12,774$1,364.64+$52.6KSRACW
4$115,497$45,585.62$13,944$1,527.86+$101.6KSRACW
5$198,892$75,309.60$15,270$1,715.87+$183.6KSRACW
6$334,016$121,202.50$16,775$1,933.09+$317.2KSRACW
7$547,628$190,230.15$18,490$2,184.87+$529.1KSRACW
8$877,445$291,482.95$20,450$2,477.63+$857.0KSRACW
9$1,375,345$436,479.30$22,697$2,819.19+$1.35MSRACW
10$2,111,018$639,398.81$25,280$3,219.02+$2.09MSRACW

SRACW vs XYLD: Complete Analysis 2026

SRACWStock

SRACW is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in SRACW shares.

Full SRACW Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this SRACW vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SRACW vs SCHDSRACW vs JEPISRACW vs OSRACW vs KOSRACW vs MAINSRACW vs QYLDSRACW vs JEPQSRACW vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.